Competing interests
No competing interests declared.is affiliated with EUROIMMUN and has no financial interests to declare.The Icahn School of Medicine at Mount Sinai has filed patent applications relating to SARS-CoV-2 serological assays and NDV-based SARS-CoV-2 vaccines which list Florian Krammer as co-inventor. Mount Sinai has spun out a company, Kantaro, to market serological tests for SARS-CoV-2. Florian Krammer has consulted for Merck and Pfizer (before 2020), and is currently consulting for Pfizer, Seqirus, 3rd Rock Ventures and Avimex. The Krammer laboratory is also collaborating with Pfizer on animal models of SARS-CoV-2.(Serological Assay, U.S. Application Serial No. 17/913,783, NDV-HXP-S, U.S. Application Serial No. 17/922,777).Reviewing editor, eLife.